National Lipid Association

 

National Lipid Association
Avatar

ASCVD Therapy Update: Can Inclisiran Improve Adherence and Change Preventive Cardiology?

By National Lipid Association FEATURING Christie Ballantyne
By National Lipid Association FEATURING Christie Ballantyne
785 views
March 19, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

48:22
Lilly Diabetes

A Journey Through Clinical Efficacy and Safety Data Comparing Two T2…

Feat. B. Hirsch

Featured Video

04:47
Novartis Cardiology

Examining MOA, Safety, and Efficacy Data for a Non-Statin Lipid-Lowe…

Session I: Drugs in the Pipeline
15:45

Management of Atherogenic Dyslipidemia and Atherosclerosis: What Are…

National Lipid Association

S. Subramanian

221 views
14:44

Bempedoic Acid: Mechanism of Action, Effects and Potential Uses

National Lipid Association

A. Goldberg

846 views
16:18

ASCVD Therapy Update: Can Inclisiran Improve Adherence and Change Pr…

National Lipid Association

C. Ballantyne

785 views
17:56

Update on Evinacumab: ANGPTL3 and Lipid Management

National Lipid Association

P. Duell

796 views
47:06

Session I Speakers Panel and Q&A

National Lipid Association